The US Food and Drug Administration (FDA) has reportedly initiated a comprehensive data collection process concerning the products manufactured by two Indian spice producers. This action follows Hong Kong's decision to suspend the sale of certain products from these companies, citing allegations of elevated levels of a cancer-causing pesticide. "The FDA is aware of the reports and is gathering additional information about the situation," an FDA spokesperson told the news agency Reuters on Friday.
In recent developments, Hong Kong authorities have temporarily suspended the sale of three spice blends from a popular Indian brand and an Everest spice mix specifically used for fish curries. Additionally, Singapore has mandated a recall of the Everest spice mix due to its detection of elevated levels of ethylene oxide. This compound is deemed unsuitable for human consumption and poses a potential risk of cancer upon prolonged exposure.
Everest has previously asserted the safety of its spice products for consumption, maintaining their suitability for culinary use. However, the other Indian spice manufacturer has yet to provide any response or comment regarding inquiries made regarding its products.
Both the Indian spices brand enjoy widespread popularity in India and regions across Europe, Asia, and North America. In light of recent actions taken by authorities in Hong Kong and Singapore, India's food regulator, the Food Safety and Standards Authority of India (FSSAI), has initiated an assessment of the quality standards upheld by these two companies.
The Spices Board of India, the governmental regulatory body overseeing spice exports, announced on Wednesday that it had formally requested information regarding the exports of the two Indian spice brands in contention from authorities in Hong Kong and Singapore. Additionally, the board stated that it is working with the companies to identify the "root cause" of the quality concerns, and inspections have commenced at their manufacturing facilities.
Also Read: Spice Board Demands Quality Check Details From MDH, Everest About Carcinogen Ingredients: Report